Physician profile
Richard S Stephen
NPI 1891880530
$7,794.84
in general payments reported to CMS, 2019-2025
27 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $138 · 2021: $134 · 2022: $203 · 2023: $1,646 · 2024: $5,196 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $1,657 · Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $1,657.19 |
| Food and Beverage | $866.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,077.92 | 2024 | |
| Applied Medical Resources Corporation | $1,264.19 | 2023 | Gelpoint V-Path |
| Shield Therapeutics INC | $250.91 | 2023-2025 | Accrufer |
| Pfizer INC. | $193.38 | 2019-2023 | |
| Abbvie INC. | $119.24 | 2019-2022 | |
| Agile Therapeutics, INC. | $83.23 | 2021-2022 | |
| Myriad Women'S Health, INC. | $79.65 | 2023 | Myrisk |
| Astellas Pharma US INC | $65.63 | 2019-2023 | Veozah |
| Biosense Webster, INC. | $63.43 | 2023 | Carto 3 |
| Therapeuticsmd, INC. | $62.49 | 2019-2022 | |
| Ethicon US, LLC | $56.56 | 2019-2025 | Surgiflo Hemostatic Matrix, Stratafix, Enseal |
| Mayne Pharma Commercial LLC | $56.25 | 2022-2025 | |
| Mylan Pharmaceuticals INC. | $54.20 | 2019-2022 | |
| Baxter Healthcare | $44.98 | 2020 | |
| Medtronic, INC. | $42.63 | 2023 | Truclear, Ligasure |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $41.54 | 2023 | Seglentis |
| Coopersurgical, INC. | $39.35 | 2019 | |
| Sumitomo Pharma America, INC. | $34.90 | 2023 | Gemtesa |
| Sage Therapeutics, LLC | $26.66 | 2025 | Zurzuvae |
| Minerva Surgical, INC | $25.61 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.17 | 2019 | |
| Allergan, INC. | $17.94 | 2019 | |
| Meditrina | $17.85 | 2025 | |
| Convatec INC. | $17.23 | 2022 | |
| Teleflex LLC | $13.68 | 2021 | |
| Hologic Sales and Service, LLC | $12.96 | 2019 | |
| Lupin INC. | $11.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Stephen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.